Skip to main content
Log in

Assessment of adverse drug reactions in psychiatric hospitals

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

A system for monitoring adverse drug reactions (ADR) in psychiatric inpatients was introduced in psychiatric hospitals in the FRG in May 1979. It consists of intensive drug monitoring (IDM) and a so-called “organized spontaneous reporting system” (OSR). ADR are rated separately according to impact on therapy and probability of causal relationship. With IDM all ADR (Grades I–III) are assessed in a randomly selected sample of inpatients. With OSR only ADR leading to discontinuation of the drugs in question (=ADR Grade III) are assessed. In 406 drug-treated inpatients monitored by IDM in the psychiatric hospitals of Berlin and Munich from May 1979 to Dec. 1981, ADR were observed in 60,4%. In 15% of IDM-patients ADR led to discontinuation of the drugs in question; with OSR the relative frequency of these Grade III ADR was 9,0% in 5096 patients monitored throughout the entire period. Life-threatening events were observed in 1,2% of patients undergoing IDM as well as 1.2% of those undergoing OSR. The most frequently observed ADR by IDM were sedation, extrapyramidal signs, disturbances of the autonomic nervous system and increase in transaminases, and by OSR Parkinsonism, akathisia, sedation, toxic delirium and increased transaminases. The relative frequency of Grade III ADR was similar for neuroleptics and antidepressants (5,4% and 5,3% in OSR); a very low relative frequency of ADR Grade III was found for tranquilizers and hypnotics (0,7% and 0,2%). Methodological aspects of this drug monitoring system are discussed in the light of current literature.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Seidl LG, Thornton GF, Cluff LE (1965) Epidemiological studies of adverse drug reactions. Am J Public Health 55: 1170–75

    Google Scholar 

  2. Borda IT, Slone D, Jick H (1968) Assessment of adverse reactions within a drug surveillance program. J Am Med Assoc 205: 99–101

    Google Scholar 

  3. Jick H, Miettinen OS, Shapiro S, Lewis GP, Siskind V, Slone D (1970) Comprehensive drug surveillance. J Am Med. Assoc 213: 1455–1460

    Google Scholar 

  4. Ogilvie RJ, Ruedy J (1967) Adverse drug reactions during hospitalization. Can Med Assoc J 97: 1450–1457

    Google Scholar 

  5. Klein U, Gikalow I, Keller M, Hoigné R (1972) “Drug monitoring” in der Medizinischen Abteilung eines Regionalspitals. Schweiz Med Wochenschr 102: 1083–1090

    Google Scholar 

  6. Hurwitz N, Wade OL (1969) Intensive hospital monitoring of adverse reactions to drugs. Br Med J 1: 531–536

    Google Scholar 

  7. Weber E, Gundert-Remy U, Walter E, Ding R, Harenberg J, v. Kenne H, Spohr U (1978) Experiences and results of a 5-year-period of hospital drug monitoring. In: Ducrot H, Goldberg M, Hoigne R, Middleton P (eds) Computer-aid to drug therapy and to drug monitoring. IFIP, North-Holland, Amsterdam, pp 35–42

    Google Scholar 

  8. Bellantuono C, Reggi V, Tognoni G, Muscettola G (1981) Comparison of practice in hospitals and community mental health centers. In: Tognoni G, Bellantuono G, Lader M (eds) Epidemiological impact of psychotropic drugs. Elsevier North-Holland Biomedical Press, Amsterdam, pp 171–187

    Google Scholar 

  9. Ayd F (1974) Fear of side effects and denial of treatment. Direct clinical data. Rational psychopharmacotherapy and the right to treatment. Ayd Med Comm Ltd, Baltimore, pp 111–116

    Google Scholar 

  10. Swett Ch (1979) Patterns of drug use in psychiatric inpatient wards. J Clin Psychiat 16: 464–468

    Google Scholar 

  11. Rüther E, Benkert O, Eckmann F, Eckmann I, Grohmann R, Helmchen H, Hippius H, Müller-Oerlinghausen B, Poser W, Schmidt LG, Stille G, Strauß A, Überla K (1980) “Drug monitoring” in psychiatrischen Kiniken. Bericht der Arbeitsgruppe für Medikamenten-Überwachung in der Psychiatrie. Drug Res 30, 8: 1181–1183

    Google Scholar 

  12. Müller-Oerlinghausen B, Schmidt LG, Rüther E (1981) Drug monitoring in psychiatry. In: Sartorius N, Helmchen H (ed) Multicentre trials, Karger, Basel, pp 101–108

    Google Scholar 

  13. Grohmann R, Strauß A, Gehr C, Rüther E, Hippius H (1980) Zur Praxis der klinischen Therapie mit Psychopharmaka. Pharmacopsychiat 13: 1–19

    Google Scholar 

  14. Schmidt LG, Niemeyer R, Müller-Oerlinghausen B (1983) Drug prescribing pattern of a psychiatric university hospital in Germany. Pharmacopsychiat 16: 35–42

    Google Scholar 

  15. Schmidt LG, Grohmann R, Helmchen H, Langscheid-Schmidt K, Müller-Oerlinghausen B, Poser W, Rüther E (1984) Epidemiology of adverse drug reactions in psychiatric hospital. Acta Psychiatr. Scand 70: 77–89

    Google Scholar 

  16. Venulet J (1977) Methods of monitoring adverse reactions to drugs. Proc Drug Res 21: 231–292

    Google Scholar 

  17. Wardell WM, Tsianco MC, Anavekar SN, Davis HT (1979) Postmarketing surveillance of new drugs. 1. Review of objectives and methodology. J Clin Pharmacol 19: 85–94

    Google Scholar 

  18. Smith MW (1981) The case control or retrospective study in retrospect. J Clin Pharmacol 21: 269–274

    Google Scholar 

  19. Feinstein AR (1974) Clinical biostatistics. 28. The biostatistical problems of pharmaceutical surveillance. Clin Pharmacol Ther 16: 110–123

    Google Scholar 

  20. Finney DJ (1965) The design and logic of a monitor of drug use. J Chron Dis 18: 77–98

    Google Scholar 

  21. Slone D, Jick H, Borda I, Feinleib TC, Muench H, Lipworth L, Beleotti C, Gilman B (1966) Drug surveillance utilising nurse monitors. Lancet 2: 901–903

    Google Scholar 

  22. Karch FE, Smith CL, Kerzner B, Mazzullo JM, Weintraub M, Lasagna L (1976) Adverse drug reactions — a matter of opinion. Clin Pharmacol Ther 19: 489–492

    Google Scholar 

  23. Karch FE, Lasagna L (1977) Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 21: 247–254

    Google Scholar 

  24. Koch-Weser J, Sellers EM, Zacest R (1977) The ambiguity of adverse drug reactions. Eur J Clin Pharmacol 11: 75–78

    Google Scholar 

  25. Blanc S, Leuenberger P, Berger JP, Brocke EM, Schelling JL (1979) Judgments of trained observers on adverse drug reactions. Clin Pharmacol Ther 25: 493–498

    Google Scholar 

  26. Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR (1979) An algorithm for the operational assessment of adverse drug reactions. 1. Background, description and instruction for use. JAMA 242: 623–632

    Google Scholar 

  27. Naranjo CA, Busto U, Sellers EM, Sander P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt EJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30: 239–245

    Google Scholar 

  28. Tallarida RJ, Murray RB, Eiben C (1979) A scale for assessing the severity of diseases and adverse drug reactions. Clin Pharmacol Ther 25: 381–390

    Google Scholar 

  29. Hutchinson TA, Leventhal JM, Kramer MS, Karch FE, Lipman AG, Feinstein AR (1979) An algorithm for the operational assessment of adverse drug reactions. 2. Demonstration of reproducibility and validity. J Am Med Assoc 242: 633–638

    Google Scholar 

  30. Leventhal JM, Hutchinson TA, Kramer MS, Feinstein AR (1979) An algorithm for the operational assessment of adverse drug reactions. 3. Result of tests among clinicians. J Am Med Assoc 242: 1991–1994

    Google Scholar 

  31. Boston Collaborative Drug Surveillance Program (1972) Adverse reactions to the tricyclic-antidepressant drugs. Lancet 1972: 529–531

  32. Downing RW, Rickels K, Meyers F (1970) Side reactions in neurotics: A comparison of two methods of assessment. J Clin Pharmacol 10: 289–297

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grohmann, R., Hippius, H., Müller-Oerlinghausen, B. et al. Assessment of adverse drug reactions in psychiatric hospitals. Eur J Clin Pharmacol 26, 727–734 (1984). https://doi.org/10.1007/BF00541933

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00541933

Key words

Navigation